Basal serum thyroglobulin measured by a second-generation assay is equivalent to stimulated thyroglobulin in identifying metastases in patients with differentiated thyroid cancer with low or intermediate risk of recurrence.

Cláudia C. D. Nakabashi,Teresa S. Kasamatsu,Felipe Crispim,Claudia A. Yamazaki,Cleber P. Camacho,Danielle M. Andreoni,Rosalia P. Padovani,Elza S. Ikejiri,Maria C.O.M. Mamone,Flávia C. Aldighieri,Jairo Wagner,Jairo T. Hidal,Vieira Jg,Rosa Paula M. Biscolla,Rui M. B. Maciel

Basal serum thyroglobulin measured by a second-generation assay is equivalent to stimulated thyroglobulin in identifying metastases in patients with differentiated thyroid cancer with low or intermediate risk of recurrence.

2014

Cláudia C. D. Nakabashi
Teresa S. Kasamatsu
Felipe Crispim
Claudia A. Yamazaki
Cleber P. Camacho
Danielle M. Andreoni
Rosalia P. Padovani
Elza S. Ikejiri
Maria C.O.M. Mamone
Flávia C. Aldighieri
Jairo Wagner
Jairo T. Hidal
Vieira Jg
Rosa Paula M. Biscolla
Rui M. B. Maciel

Background: Guidelines for the follow-up of differentiated thyroid cancer (DTC) recommend the measurement of TSH-stimulated thyroglobulin (s-Tg) instead of basal

Keywords:

Basal (phylogenetics)
Oncology
Thyroid cancer
Internal medicine
Thyroglobulin
Pathology
Medicine
Text mining
Endocrinology
serum thyroglobulin
in patient
intermediate risk

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations